Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-16-013450

← back to feed
Filed
Nov 14, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · Nov 14, 2016 7.21M sh
Shares Diluted Q1 2017 · Sep 30, 2016 7.15M sh
Shares Diluted Q1 2017 · Sep 30, 2015 4.91M sh
Stockholders Equity Q1 2017 · Sep 30, 2016 −$3.42M
Stockholders Equity Q1 2017 · Jun 30, 2016 −$3.04M
Current Liabilities Q1 2017 · Sep 30, 2016 $1.24M
Current Liabilities Q1 2017 · Jun 30, 2016 $1.09M
Total Liabilities Q1 2017 · Sep 30, 2016 $3.84M
Total Liabilities Q1 2017 · Jun 30, 2016 $3.54M
Current Assets Q1 2017 · Sep 30, 2016 $413.91K
Current Assets Q1 2017 · Jun 30, 2016 $495.94K
Total Assets Q1 2017 · Sep 30, 2016 $413.91K
Total Assets Q1 2017 · Jun 30, 2016 $495.94K
Operating Cash Flow Q1 2017 · Sep 30, 2015 −$75.28K
Cash And Equivalents Q1 2017 · Sep 30, 2015 $210
Cash And Equivalents Q1 2017 · Jun 30, 2015 $486
Sga Expense Q1 2017 · Sep 30, 2015 $453.49K
Net Income Q1 2017 · Sep 30, 2015 −$554.85K
Operating Income Q1 2017 · Sep 30, 2015 −$554.85K